IPSC Century Therapeutics, Inc.
Healthcare$2.17-3.98%ClosedMarket Cap: $187.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.74
P/S
0.00
EV/EBITDA
-1.94
DCF Value
$2.28
FCF Yield
-49.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-53.2%
ROA
-33.0%
ROIC
-37.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-25.5M | $-21.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-20.7M | $-19.2M | $— | — |
| FY null | $109.2M | 88.0% | $-15.0M | $-9.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-36.1M | $-34.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-34.7M | $-32.5M | $— | — |
| Q1 null | $109.2M | 100.0% | $74.2M | $76.6M | $— | — |
| Q4 null | $4.2M | 100.0% | $-37.3M | $-36.1M | $— | — |
| FY null | $6.6M | 100.0% | $-138.1M | $-126.6M | $— | — |
| Q3 null | $791.0K | 100.0% | $-34.8M | $-31.2M | $— | — |
| Q2 null | $771.0K | 100.0% | $-34.8M | $-31.2M | $— | — |
| Q1 null | $855.0K | 100.0% | $-31.3M | $-28.1M | $— | — |
| Q4 2023 | $268.0K | -8219.4% | $-43.8M | $-39.4M | $-0.66 | — |